4.7 Article

Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Impact on glucometric variables and quality of life of the advanced hybrid closed-loop system in pediatric and adolescent type 1 diabetes

Alfonso Lendinez-Jurado et al.

Summary: The study evaluated the impact of using the MiniMed 780G closed-loop system in pediatric and adolescent patients with diabetes who were previously treated with a continuous subcutaneous insulin infusion pump and intermittent glucose monitoring. The results showed improvement in blood glucose control from the first 48 hours after the automation of the system, which was maintained for 6 months.

JOURNAL OF DIABETES (2023)

Article Endocrinology & Metabolism

Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users

Julien Da Silva et al.

Summary: The preliminary performance evaluation of the MiniMed 780G system in real-world settings shows that most users are able to achieve good glycemic control and minimize hypoglycemia, indicating the effectiveness of the system.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Article Endocrinology & Metabolism

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration

Alice L. J. Carr et al.

Summary: C-peptide declines in type 1 diabetes, with younger patients experiencing more rapid loss of beta-cells.

DIABETES (2022)

Article Endocrinology & Metabolism

Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users

Arcelia Arrieta et al.

Summary: This empirical study investigated the real-world glycaemic outcomes and goals achieved by users of the MiniMed 780G advanced hybrid closed loop system in different age groups of type 1 diabetes patients. The results show that both patients aged 15 years or younger and patients aged older than 15 years achieved good blood glucose control with the use of the AHCL system, in line with the international consensus recommendations.

DIABETES OBESITY & METABOLISM (2022)

Article Endocrinology & Metabolism

Predictors of time in target glucose range in real-world users of the MiniMed 780G system

Javier Castaneda et al.

Summary: This study aimed to investigate predictors of improved sensor glucose range in diabetes patients using the Minimed 780G system. The findings suggest that optimized pump settings and other modifiable factors play a significant role in achieving glycemic targets.

DIABETES OBESITY & METABOLISM (2022)

Review Endocrinology & Metabolism

C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Ernesto Maddaloni et al.

Summary: C-peptide measurement is valuable in autoimmune diabetes but limited in type 2 diabetes due to confounding factors like insulin resistance. Standardization issues exist that may affect comparability between different laboratories.

DIABETES OBESITY & METABOLISM (2022)

Article Medicine, General & Internal

Increased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain

Isabel Leiva-Gea et al.

Summary: This study examined the impact of the COVID-19 pandemic and lockdown measures on the presenting characteristics of newly diagnosed type 1 diabetes in Spanish children. The results showed changes in age distribution and an increase in the occurrence of diabetic ketoacidosis (DKA) at onset of type 1 diabetes during the pandemic period.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Endocrinology & Metabolism

Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes

Barbara Piccini et al.

Summary: AHCL MiniMed (TM) 780G allows for rapid and sustained improvement in glycemic control in young patients with T1D, reaching recommended time in range (TIR). Teenagers showed good adherence to the technology, with optimal TIR maintained over time compared to younger children. Stricter settings were associated with better metabolic control without an increase in severe hypoglycemia occurrence.

PEDIATRIC DIABETES (2022)

Article Endocrinology & Metabolism

Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England

Sze May Ng et al.

Summary: The National Health Service (NHS) England Closed Loop Study in Children and Young People revealed that the use of Hybrid closed-loop (HCL) systems for 6 months improved glycemic control, reduced frequency of hypoglycemia, and enhanced quality of sleep for children and young people. Additionally, parents and caregivers experienced improvements in hypoglycemia fear and sleep quality after 6 months.

DIABETIC MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Real-world outcomes with different technology modalities in type 1 diabetes

Pilar Beato-Vibora et al.

Summary: This study evaluated the real-world benefits of different treatment modalities for T1D. Results showed that HCL offers the maximum benefit in terms of maintaining time in range and protecting against hypoglycemia.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)

Article Endocrinology & Metabolism

Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus

Gianluca Tornese et al.

Summary: The study found that patients using the advanced closed-loop system had a decrease in HbA1c within six months, achieved the TIR >70% target earlier and more stably, without increasing hypoglycemia or BMI. Previous users of the standard hybrid closed-loop system did not show significant improvement. Children under the age of 14 and individuals with the worst glycemic control seemed to benefit the most from the advanced closed-loop pumps.

FRONTIERS IN ENDOCRINOLOGY (2021)

Editorial Material Endocrinology & Metabolism

Age of onset of diabetes and all-cause mortality

Gary Yee Ang

WORLD JOURNAL OF DIABETES (2020)

Article Medicine, General & Internal

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

Aidin Rawshani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Range of Risk Factor Levels Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus

Aidin Rawshani et al.

CIRCULATION (2017)

Article Endocrinology & Metabolism

Cardiovascular Function/Dysfunction in Adolescents with Type 1 Diabetes

Kristen J. Nadeau et al.

CURRENT DIABETES REPORTS (2011)